Home
Home
  • Home
  • About Us About Us
    • Overview
    • Who we are
    • Why we provide advice
    • What are health technologies
    • Meetings
    • News
    • Who we work with
    • Contact Us
  • What We Do What We Do
    • Overview
    • Our Strategy
    • Work programme
    • Range of advice products
    • Quarterly Bulletin of advice
    • Early HTA Advice Service
  • Our Advice
  • Request Advice Request Advice
    • Overview
    • Form for requesting advice
  • Get Involved Get Involved
    • Overview
    • Contribute to advice
    • NHS boards
    • Patient and Public Involvement
    • Industry Involvement
    • Observe a council meeting
    • DOI Form

SHTG Innovative Medical Technology Overview

  • Home
  • Our Advice
  • OWise mobile app and website for supporting women with breast cancer

Title

Output Type

Speciality

Published

Title

OWise mobile app and website for supporting women with breast cancer

Output Type

SHTG Innovative Medical Technology Overview

Speciality

Cancer

Published

10 January 2020

Key findings

There are currently no published studies on the OWise app that report patient health outcomes. 

Patients reported positive experiences of using the OWise app.

Whether the OWise app is cost saving or not is uncertain due to the lack of directly applicable cost and outcome data.

What were we asked to look at?

We were asked to provide a high level overview of the OWise app.

The OWise app is designed for use throughout the patient journey, in conjunction with standard treatments for breast cancer, as a replacement for paper-based support tools. OWise can be accessed as an app on smartphones and tablets, or through a website (http://www.owise.uk/).

The OWise app is CE marked as a ‘medical device class 1’ (low-risk device). The OWise app and website (‘OWise app’) are synchronised so that patient information is up-to-date, regardless of how or where patients access it.

Why is this important?

In Scotland, breast cancer is the most commonly diagnosed cancer in women: in 2017 there were 4,706 new diagnoses. Unlike other PRO-generating apps or systems, the OWise app is freely available to patients and the NHS in Scotland. In the case of the beta-version currently being piloted in NHS Lothian, the OWise app is also uniquely able to feed PRO data directly into the TrakCare® electronic patient Record system where it can be accessed by the relevant clinical team.

The OWise app can be used at multiple points in the patient care pathway to replace, complement, or expand on, current paper-based tools, for example, as a replacement for paper-based chemotherapy diaries for recording side-effects and symptoms during treatment.

Referred by 

Px HealthCare, manufacturer of the technology.

Download icon
Download Advice
pdf (747 KB)

Connect with Us

Please let us know if you'd like to receive regular updates on our work.


Last Updated: 31 January 2022

Scottish Health Technologies Group

© 2021, All rights reserved

  • Accessibility
  • Respecting your privacy
  • Cookies
  • Healthcare Improvement Scotland Website
  • Find us on Twitter
  • Freedom of Information

Tell us what you think


We'd love to hear your views

Was our advice useful?  Did you find what you were looking for on our website?